LAS VEGAS, March 3, 2026 /PRNewswire/ -- Avaí Bio, Inc. (OTCQB: AVAI) ("Avaí" or the "Company"), an emerging biotechnology company developing transformative cell-based therapies for diabetes, ...
LAS VEGAS, May 20, 2026 /PRNewswire/ -- Avaí Bio, Inc. (OTCQB: AVAI) ("Avaí" or the "Company"), an emerging biotechnology company developing transformative cell-based therapies for diabetes, ...
The MarketWatch News Department was not involved in the creation of this content. Issued on behalf of Avaí Bio, Inc. VANCOUVER, BC, March 3, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results